Bioequivalence of generic preparations of levothyroxine: Letters to the editor

Clinical Endocrinology

Volumn 71, Issue 4, 2009, Pages 603-

  Toft, Anthony ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; THYROTROPIN;

BIOEQUIVALENCE; CELIAC DISEASE; DRUG ABSORPTION; DRUG MEGADOSE; DRUG METABOLISM; DRUG QUALITY; HORMONE SUBSTITUTION; HUMAN; LETTER; MEDICAL SOCIETY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; THYROTROPIN BLOOD LEVEL;

DRUGS, GENERIC; HUMANS; HYPOTHYROIDISM; THERAPEUTIC EQUIVALENCY; THYROTROPIN; THYROXINE;

EID: 69949123722     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03647.x     Document Type: Letter

References (2)

1. Morris, J.C. (2009) How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clinical Endocrinology, 70, 671 673.
2. Toft, A.D. (2005) Which thyroxine? Thyroid, 15, 124 126.